548 filings
Page 9 of 28
8-K
5t07y2a
3 May 16
Abiomed Announces Q4 Fy 2016 Revenue of $94.0 Million, Up 39% Over Prior Year
12:00am
8-K
7iqs38
8 Apr 16
Abiomed Impella® Therapy Receives Fda Approval for Cardiogenic Shock after Heart Attack or Heart Surgery
12:00am
8-K
1siromr
21 Mar 16
Regulation FD Disclosure
12:00am
8-K
rk1he
11 Feb 16
Abiomed Announces Appointments of Jeannine Rivet and Christopher Van Gorder
12:00am
S-8
q5u61
5 Feb 16
Registration of securities for employees
12:00am
8-K
s4ynsf74rec4o0gvap23
4 Feb 16
Abiomed Announces Q3 Fy 2016 Revenue of $85.8 Million, Up 38% Over Prior Year
12:00am
8-K
j6jecj4
11 Jan 16
Abiomed Announces Preliminary Q3 Fy 2016 Revenue of $85.8 Million, Up 38% Over Prior Year
12:00am
8-K
esa3ov3zi676t umntsp
15 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
hb0jidp nvidh
29 Oct 15
Abiomed Announces Q2 Fy 2016 Revenue of $76.4 Million, Up 47% Over Prior Year
12:00am
S-8
eqzfq3inzjhv
14 Aug 15
Registration of securities for employees
12:00am
8-K
zdrgipjcyn f56tcfl3
14 Aug 15
Departure of Directors or Certain Officers
12:00am
8-K
28b6zi
4 Aug 15
Abiomed Announces Q1 Fy 2016 Revenue of $73.4 Million, Up 50% Over Prior Year
12:00am
ARS
tor4bvjr
9 Jul 15
Annual report to shareholders
12:00am
8-K
jcfudnaxb8c3
29 Jun 15
United States Department of Justice Closes Investigation into Abiomed’s Impella 2.5
12:00am
8-K
bjk5q7dy3b 47c7mug
19 Jun 15
Departure of Directors or Certain Officers
12:00am
8-K
lb1jwk7rshil 321ez3b
1 Jun 15
Abiomed to Appoint New Chief Financial Officer Michael Tomsicek
12:00am